4//SEC Filing
Beeler Brian K 4
Accession 0001209191-21-048786
CIK 0001492426other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:23 PM ET
Size
9.5 KB
Accession
0001209191-21-048786
Insider Transaction Report
Form 4
Beeler Brian K
EVP, General Counsel
Transactions
- Tax Payment
Ordinary Shares
2021-07-28$102.50/sh−2,573$263,733→ 99,959 total - Award
Ordinary Shares
2021-07-28+5,806→ 102,532 total - Award
Performance Restricted Stock Units (PSUs)
2021-07-28+11,612→ 11,612 total→ Ordinary Shares (11,612 underlying)
Footnotes (3)
- [F1]On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On July 28, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above. The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023.
- [F2]Includes 1,049 ordinary shares of the Issuer acquired by the reporting person on June 1, 2021 pursuant to an employee stock purchase program.
- [F3]Each PSU represents a contingent right to receive one ordinary share of the Issuer.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001641580
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:23 PM ET
- Size
- 9.5 KB